The 7th International Medicine in Addiction (IMiA) Conference will bring together more than 600 attendees within the industry including a diverse international community of general practitioners, psychiatrists, psychologists, physicians and practice nurses who have an interest in, or practice in the area of addiction medicine.
Overseas speakers and delegates are expected to attend along with locals. The 2023 conference will be the first IMiA to run as a hybrid event with both an in-person and virtual audience, further expanding its reach and diversifying its audience.
Show your support for the 7th International Medicine in Addiction (IMiA) Conference by becoming a partner, sponsor or exhibitor. A range of packages are available to fit your budget and commercial needs and can be accessed by reading the sponsorship prospectus.
Major Partner
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow.
AbbVie’s commitment to eliminating the hepatitis C virus (HCV) goes beyond medicine. Today, people with HCV are harder to reach and many live among marginalised communities. By concentrating our efforts, sharing learnings and scaling what works, we aim to find sustainable solutions that will move us closer to a world free of HCV.
For more information about AbbVie, please visit us at www.abbvie.com.au. Follow @abbvie_AU on Twitter, Facebook, Instagram or our LinkedIn page.
Camurus is a Swedish research-based pharmaceutical company committed to developing innovative and differentiated medicines for the treatment of severe and chronic conditions. New drug products are conceived based on the proprietary lipid-based FluidCrystal® drug delivery technologies and an extensive research and development expertise.
Camurus Australia’s focus is on opioid dependence, with the aim of simplifying treatment and removing the burden and stigma for patients and their families.
If you wish to learn more about Camurus’ medications, please visit the Buvidal website
Supporting Partner
Baclofen Treatment for Alcoholism
The Pharmacotherapy Area-Based Networks (PABNs) support health professionals across Victoria to prevent, identify and manage opioid dependence, including through access to specialist and peer support, clinical networks and education programs, expert advice on best practice and up-to-date medical findings, and navigating and optimising systems.
Each of the two metropolitan and three regional networks provide innovative and flexible approaches to meeting local needs, recognising the diverse needs of practitioners and patients, as well as collaborate on approaches to important issues with state-wide significance.
For more information about the PABNs including local contacts, visit www.pabn.org.au
ToxLogic offers client-specific advice and specialised testing for drugs and alcohol.
Our testing options include:
- drugs, alcohol and steroids in hair,
- drugs, alcohol and steroids in nails and
- PEth testing for alcohol using a dried blood spot.
ToxLogic is also NATA accredited for drug testing using urine and oral fluid, a regime more commonly used by workplaces. We also provide breath alcohol testing if required.
We advise clients on the most appropriate and cost-effective choice for their circumstances and provide full support from sample collection to result interpretation.
Welcome Reception Sponsor
The Victorian Responsible Gambling Foundation supports people affected by gambling addiction and harm, including family and friends. We take a public health approach to our work, which means we focus on prevention, early intervention and support for those who are particularly vulnerable to gambling harm as well as those living in regional and rural communities.
We fund and work closely with organisations across Victoria to provide free and confidential Gambler’s Help services to people experiencing harm from their own or someone else’s gambling.
For more information, visit www.responsiblegambling.vic.gov.au
Breakfast Symposium Sponsor
AbbVie
Camurus Pty Ltd
Camurus is a Swedish research-based pharmaceutical company committed to developing innovative and differentiated medicines for the treatment of severe and chronic conditions. New drug products are conceived based on the proprietary lipid-based FluidCrystal® drug delivery technologies and an extensive research and development expertise.
Camurus Australia’s focus is on opioid dependence, with the aim of simplifying treatment and removing the burden and stigma for patients and their families.
If you wish to learn more about Camurus’ medications, please visit the Buvidal website
Exhibitors
AIMedical International Pty Ltd is the distributor of rehabilitation training devices and Transcranial Magnetic Stimulation (TMS) Devices.
Numerous papers have demonstrated the efficacy of TMS in treating substance abuse, addiction, and craving. (Del Felice et al., 2016): Mishra et al. (2015), Martinez et al. (2018)
See our website for more information or contact us at sales@aimedical.com.au
Cannatrek is an Australian supplier of local and internationally produced medications. Cannatrek is here to assist in your Medicinal Cannabis prescribing journey. Whether you are new to medicinal cannabis or a current Authorised Prescriber, Cannatrek offers a simple and clear approach.
Indivior is the world leader in addiction treatment with over 20 years’ experience and a unique patient‐focused approach. Our endeavour is to understand the journey of individuals suffering with addiction.
We partner with healthcare professionals, the public, policymakers, and payers to ensure people suffering from addiction are treated just like any other patients suffering from a chronic, relapsing medical condition.
Sana Health Group
Newly formed, Sana Health Group aims to be the Australasian leader in behavioural health. Our mission is to support more people towards a better future.
Sana brings together the leading providers in behavioural health offering prevention and treatment for addiction, mental health, and eating disorders.
Sonoray Pty Ltd
MagVenture is represented in Australia and New Zealand by Sonoray Pty Ltd. Our partnership extends over more than 25 years. Our TMS systems are all TGA registered for use in MDD, Anxiety, OCD and Addiction. We have systems installed in every state of Australia and in New Zealand and offer a range of systems to suit all needs and budgets.
At Viatris, we see healthcare not as it is but as it should be. We act courageously and are uniquely positioned to be a source of stability in a world of evolving healthcare needs.
We accomplish this through our broad portfolio that ranges from branded medicines to generics, including complex and branded generics and over-the-counter products across more than 10
major therapeutic areas.
We are a leading supplier of medicines to the Pharmaceutical Benefits Scheme (PBS). In fact, Viatris contributes to 41 out of the top 50 PBS products sold by volume.
We have more than 800 passionate employees in Australia, with our headquarters in Sydney, NSW and manufacturing and distribution sites in Carole Park and Bundamba, Queensland.
